In June 2022, the Company amended and restated its 2019 Equity Incentive Plan (the “2019 Plan”), primarily authorizing an additional 3,300,000 shares available for future grant. As of March 30, 2025, 1,508,177 shares remained registered and available for future grant under the 2019 Plan.

At its discretion, the Company grants share option awards, nonvested share awards and nonvested share unit awards to certain employees, as defined by ASC 718, Compensation—Stock Compensation, under the Company’s 2019 Plan, and accounts for its share-based compensation in accordance with ASC 718. The Company recognized $0.7 million in share-based compensation expense for each of the 13-week periods ended March 30, 2025 and March 31, 2024.

Share option awards granted by the Company generally vest and become exercisable in four equal annual installments of 25% per year with a maximum life of ten years. The exercise price of share option awards is equal to the quoted market price of the Company’s common stock on the date of grant. The Company granted 315,000 and 272,000 share option awards in the first quarter of fiscal 2025 and 2024, respectively, with a weighted-average grant-date fair value of $0.91 and $2.52 per share option award, respectively.

A summary of the status of the Company’s share option awards is presented below:


	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding at December 29, 2024		509,660		$	4.67
Granted		315,000			1.18
Forfeited		(3,375	)		4.80
Outstanding at March 30, 2025		821,285		$	3.33		7.97	$	—
Exercisable at March 30, 2025		302,222		$	4.26		5.35	$	—
Vested and Expected to Vest at March 30, 2025		812,727		$	3.34		7.95	$	—

The aggregate intrinsic value represents the total pretax intrinsic value, based upon the Company’s most recent closing stock price of $0.97 as of March 30, 2025, which would have been received by the share option award holders had all share option award holders exercised their share option awards as of that date.

The fair value of each share option award on the date of grant was estimated using the Black-Scholes method based on the following weighted-average assumptions:


	13 Weeks Ended
	March 30, 2025			March 31, 2024
Risk-free interest rate		4.2	%		4.2	%
Expected term	7.5 years			7.5 years
Expected volatility		81.4	%		77.6	%
Expected dividend yield		—			4.1	%

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the share option award; the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; and the expected dividend yield is based upon the Company’s dividend rate at the time fair value is measured and future expectations.

As of March 30, 2025, there was $0.8 million of total unrecognized compensation expense related to share option awards granted. That expense is expected to be recognized over a weighted-average period of 3.5 years.

Nonvested share awards granted by the Company vest for employees from the date of grant in four equal annual installments of 25% per year. Nonvested share awards and nonvested share unit awards granted by the Company to non-employee directors for their service as directors, as defined by ASC 718, generally vest 100% on the earlier of (a) the date of the Company’s next annual stockholders meeting following the grant date, or (b) the first anniversary of the grant date.

Nonvested share awards become outstanding when granted and are delivered to the recipient upon their vesting. Vested share unit awards, including any dividend reinvestments, are delivered to the recipient on the tenth business day of January following the year in which the recipient’s service to the Company is terminated, at which time the units convert to shares and become outstanding. The total fair value of nonvested share awards which vested during the first quarter of fiscal 2025 and 2024 was $0.2 million and $0.8 million, respectively. No nonvested share unit awards vested during the first quarter of fiscal 2025 and 2024.

The Company granted 262,980 and 276,660 nonvested share awards in the first quarter of fiscal 2025 and 2024, respectively. The weighted-average grant-date fair value per share of the Company’s nonvested share awards granted in the first quarter of fiscal 2025 and 2024 was $0.99 and $3.58, respectively. No nonvested share unit awards were granted during the periods presented.

A summary of the status of the Company’s nonvested share awards is presented below:


	Shares			Weighted- Average Grant- Date Fair Value
Balance at December 29, 2024		691,800		$	7.24
Granted		262,980			0.99
Vested		(223,685	)		9.81
Forfeited		(8,870	)		7.31
Balance at March 30, 2025		722,225		$	4.17

To satisfy employee minimum statutory tax withholding requirements for nonvested share awards that vest, the Company withholds and retires a portion of the vesting common shares, unless an employee elects to pay cash. In the first quarter of fiscal 2025, the Company withheld 90,672 common shares with a total value of $0.1 million. This amount is presented as a cash outflow from financing activities in the accompanying interim unaudited condensed consolidated statement of cash flows.

As of March 30, 2025, there was $2.6 million of total unrecognized compensation expense related to nonvested share awards, which is expected to be recognized over a weighted-average period of 2.7 years. As of March 30, 2025, there was no remaining unrecognized compensation expense related to nonvested share unit awards.